Using A Flowthrough Cell Patents (Class 600/352)
  • Patent number: 9589686
    Abstract: Disclosed herein are apparatus and methods for detecting and quantifying contaminants in aqueous solutions. In one embodiment, an apparatus for the detection of contaminants within a liquid comprises a sensor and a controller. The sensor comprises a film and a transducer configured such that, during use, a first surface of the transducer is in fluid communication with a liquid, and the film is disposed between the first surface and the liquid. The film can be a polymeric material capable of hindering the transport of a non-desired species therethrough. The controller is in operational communication to the transducer, and is configured to determine the concentration of contaminants within the liquid.
    Type: Grant
    Filed: November 16, 2006
    Date of Patent: March 7, 2017
    Assignee: General Electric Company
    Inventors: Radislav Alexandrovich Potyrailo, David James Monk, Ryo Tamaki
  • Patent number: 9239386
    Abstract: Embodiments relate to integrated sonic sensors having a transmitter, a receiver and driver electronics integrated in a single, functional package. In one embodiment, a piezoelectric signal transmitter, a silicon microphone receiver and a controller/amplifier chip are concomitantly integrated in a semiconductor housing. The semiconductor housing, in embodiments, is functional in that at least a portion of the housing can comprise the piezoelectric element of the transmitter, with an inlet aperture opposite the silicon microphone receiver.
    Type: Grant
    Filed: October 5, 2011
    Date of Patent: January 19, 2016
    Assignee: Infineon Technologies AG
    Inventors: Klaus Elian, Horst Theuss
  • Publication number: 20140336487
    Abstract: Methods, structures, and systems are disclosed for biosensing and drug delivery techniques. In one aspect, a? device for detecting an analyte and/or releasing a biochemical into a biological fluid can include an array of hollowed needles, in which each needle includes a protruded needle structure including an exterior wall forming a hollow interior and an opening at a terminal end of the protruded needle structure that exposes the hollow interior, and a probe inside the exterior wall to interact with one or more chemical or biological substances that come in contact with the probe via the opening to produce a probe sensing signal, and an array of wires that are coupled to probes of the array of hollowed needles, respectively, each wire being electrically conductive to transmit the probe sensing signal produced by a respective probe.
    Type: Application
    Filed: August 31, 2012
    Publication date: November 13, 2014
    Inventors: Joseph Wang, Joshua Ray Windmiller, Roger Narayan, Phillip Miller, Ronen Polsky, Thayne L. Edwards
  • Publication number: 20140316219
    Abstract: A method for diagnosing a body malfunction is provided. At least one change in urinary parameter values, being indicative of the body malfunction, is monitored and detected. A volumetric urinary output of kidneys is monitored using a urine flow monitoring apparatus having a low flow metering device. It is determined whether a change exists in at least one of a volume value of the volumetric urinary output, and a trend of the corresponding urinary parameter value during a predetermined period. Signals are received from a plurality of electrodes, representing the urinary parameter values. The body malfunction is detected based on the determination of the change in at least one of the volume value and the trend.
    Type: Application
    Filed: June 30, 2014
    Publication date: October 23, 2014
    Inventors: Ilan Paz, Martin Clive Henry Jackson, Stanley Chimes
  • Publication number: 20130202721
    Abstract: A system is disclosed that extracts bodily fluid to a reaction chamber for monitoring a substance or property of the patient fluid. In one embodiment, a pump is used to advance the sample of bodily fluid through a filter to produce a filtrate. Another pump advances filtrate into the reaction chamber, while another pump advances reactant into the reaction chamber. A sensor in communication with the reaction chamber determines a concentration of nitric oxide or one of its metabolic products. Methods are also disclosed.
    Type: Application
    Filed: March 14, 2013
    Publication date: August 8, 2013
    Inventor: James H. Silver
  • Patent number: 8217217
    Abstract: A wearable article comprising a dehydration indicator adapted to measure a urine ionic strength correlated to a specific gravity of the wearer's urine and provide a visible signal when the urine ionic strength reaches a value corresponding to a predetermined threshold of the specific gravity. The wearable article may be a disposable absorbent article. The dehydration indicator may also be comprised in an insert for use with a wearable article. The dehydration indicator may provide qualitative or quantitative information about the ionic strength of the wearer's urine.
    Type: Grant
    Filed: March 7, 2008
    Date of Patent: July 10, 2012
    Assignee: The Procter & Gamble Company
    Inventors: Joseph Raymond Diehl, Donald Carroll Roe, Patrick Jay Allen
  • Patent number: 7548773
    Abstract: Methods and devices for the measurement of clinically relevant analytes in fluids are provided. The devices and methods are particularly relevant for detection of glucose in blood and allow internal calibration of measurements. One device includes a flow path for conducting the fluid through the device; a predetermined amount of the analyte arranged on the flow path such that the analyte mixes with fluid that passes it to form a calibration sample of the fluid and detector means arranged on the flow path for detecting respective analyte levels in an unadulterated sample of the fluid and in the calibration sample. Another device provides a predetermined amount of a calibration analyte of a different species to the clinically relevant analyte arranged on the flow path, and first and second detector means for detecting the levels of the clinically relevant analyte and the calibration analyte.
    Type: Grant
    Filed: February 16, 2005
    Date of Patent: June 16, 2009
    Assignee: PA Consulting Services Ltd.
    Inventor: Michael Noble
  • Patent number: 7041057
    Abstract: A tissue interface device (10) suitable for positioning on or about one or more artificial openings in a biological membrane of an organism and for coupling to a monitor and control unit and a vacuum source. The tissue interface device (10) comprises a housing (100), a sensor channel (130), and a sensor (150). The housing (100) defines an orifice (120), the orifice (120) having an open inlet port (122) on the bottom end (102) of the housing (100) and a distal end (124) that is in fluid communication with the sensor channel (130). The orifice (120) is in fluid communication with fluid that flows from the artificial opening formed in the biological membranes. The sensor channel (130) is for coupling to, and fluid communication therewith, the vacuum source. The sensor (150) is positioned in the sensor channel (130) in a flow path of the fluid for sensing a characteristic of the fluid as it flows out from the artificial opening. The sensor generates a sensor signal representative thereof.
    Type: Grant
    Filed: November 17, 2000
    Date of Patent: May 9, 2006
    Assignee: SpectRx, Inc.
    Inventors: Mark L. Faupel, Krishna Kumar, J. David Farquhar, Mark Vreeke, Alan Smith, Michael Hatch, Teresa Woods
  • Patent number: 6591126
    Abstract: The invention concerns a microdialysis system comprising a microdialysis probe (12) that can be inserted into organic tissue (10) and has a dialysis membrane (28) to separate a probe channel (18) filled with perfusion fluid from the tissue (10), a sensor cell (14) to determine the concentration of components and especially glucose in the perfusion fluid that is conveyed from the microdialysis probe (12) and a transport device (16) to convey the perfusion fluid through the probe channel (18) of the microdialysis probe (12) to the sensor cell (14).
    Type: Grant
    Filed: July 20, 2001
    Date of Patent: July 8, 2003
    Assignee: Roche Diagnostics Corporation
    Inventors: Josef Roeper, Michael Schoemaker, Christian Hoerauf